Change in Ratings
Blockbuster(BBI Quote) upgraded at JPMorgan from neutral to overweight, JPMorgan said. Fourth-quarter results should meet or beat consensus analyst estimates on March 6. Also believe there's upside potential for 2008 guidance.Chemtura(CEM Quote) upgraded at Goldman Sachs to buy from neutral based on valuation and potential for additional earnings momentum. Note that fourth-quarter results were the first time CEM beat consensus estimates since 2006. Price target at $11.
Forest Laboratories(FRX Quote) downgraded at FBR from outperform to market perform. New analyst also set a $42 price target. Company will face an uphill battle bringing new products to the market.
Minerals Technology(MTX Quote) downgraded at Goldman Sachs to neutral from buy based on relative valuation. See progress in turnaround story but note multiple unprofitable growth projects (SYNSIL, Coating PCC, Filler Fiber) in recent years. Believe other names are more attractive currently. Maintained $77 price target. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.50 | 1,106.41 | 2,190.31 | 35.40 |
Oil *
71.66
|
|
UP
65.67
|
UP
4.06
|
DOWN
0.55
|
UP
0.58
|
10 Yr
3.54%
SPDR Gold
109.32
|
|
+0.63%
|
+0.37%
|
-0.03%
|
+1.67%
|
Data delayed 20 minutes |
Connect with TheStreet